Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.47 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.47 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | PDK1 | Q15118 | 5/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 5/20 | 0.44 |
| ▸ | PDK3 | Q15120 | 5/20 | 0.44 |
| ▸ | PDK4 | Q16654 | 5/20 | 0.44 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29659945 | 1.00 | POLB (0.51) | POLBL3MBTL1ESR1GAASMN1; SMN2 | |
| SCHEMBL9230128 | 1.00 | POLB (0.51) | POLBL3MBTL1ESR1GAASMN1; SMN2 | |
| SCHEMBL15222054 | 1.00 | POLB (0.51) | POLBL3MBTL1ESR1GAASMN1; SMN2 | |
| Citric Acid SCHEMBL10413701 | 0.80 | CHRM2 (0.45) | POLBL3MBTL1ESR1GAASMN1; SMN2 | |
| SCHEMBL7733992 | 0.79 | NOTUM (0.55) | SMN1; SMN2CHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL811795 | 0.79 | NOTUM (0.55) | SMN1; SMN2CHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL31672940 | 0.79 | NOTUM (0.55) | SMN1; SMN2CHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL6890897 | 0.79 | NOTUM (0.55) | SMN1; SMN2CHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL6114443 | 0.78 | POLB (0.47) | POLBL3MBTL1ESR1GAASMN1; SMN2 | |
| SCHEMBL14705669 | 0.78 | POLB (0.47) | POLBL3MBTL1ESR1GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110117282-A | A kind of zinc ion fluorescent compound and the preparation method and application thereof | 五邑大学 | 2019-08-13 | — | — | CN | claimed |
| WO-2024116207-A1 | ADAR1 INHIBITORS AND METHODS OF USING THE SAME | AVAMMUNE THERAPEUTICS INC. (IN) | 2024-06-06 | — | — | WO | disclosed |
| CN-116239529-B | Preparation method of N-methyltetrahydroquinoline alkaloid with participation of carbon dioxide | 山西大学 | 2024-05-24 | — | — | CN | disclosed |
| EP-3681885-B1 | TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS | FORMA THERAPEUTICS INC (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023244815-A1 | MOLECULAR GLUE DEGRADERS AND METHODS OF USING THE SAME | MONTE ROSA THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| CN-116768733-A | Aryl cyclic ammonium salt arylation and silicon-based method | 中国科学技术大学 | 2023-09-19 | — | — | CN | disclosed |
| CN-116239529-A | Preparation method of N-methyltetrahydroquinoline alkaloid with participation of carbon dioxide | 山西大学 | 2023-06-09 | — | — | CN | disclosed |
| WO-2021130638-A1 | DIACYLGLYCEROL KINASE MODULATING COMPOUNDS | CARNA BIOSCIENCES, INC. (JP) | 2021-07-01 | — | — | WO | disclosed |
| WO-2020228640-A1 | ZINC ION FLUORESCENT PROBE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | 五邑大学 | 2020-11-19 | — | — | WO | disclosed |
| CN-110117282-A | A kind of zinc ion fluorescent compound and the preparation method and application thereof | 五邑大学 | 2019-08-13 | — | — | CN | disclosed |
| US-5962731-A | MODIFY LIPID METABOLISM; SKIN DISORDERS,; AUTOIMMUNE DISEASES; FATTY ACID METABOLISM; ANTITUMOR AGENTS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1999-10-05 | — | — | US | disclosed |
| EP-0678087-B1 | COMPOUNDS HAVING SELECTIVE ACTIVITY FOR RETINOID X RECEPTORS, AND MEANS FOR MODULATION OF PROCESSES MEDIATED BY RETINOID X RECEPTORS | LIGAND PHARM INC (US) | 1999-03-17 | — | — | EP | disclosed |
| US-5780676-A | BICYCLIC BENZYL, PYRIDINYL, THIOPHENE, FURANYL, PYRROLE, AND POLYENOIC ACID DERIVATIVES | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1998-07-14 | — | — | US | disclosed |
| CN-1150799-A | Benzoheterocyclic derivatives | OTSUKA PHARMA CO LTD (JP) | 1997-05-28 | — | — | CN | disclosed |
| EP-0678087-A1 | COMPOUNDS HAVING SELECTIVE ACTIVITY FOR RETINOID X RECEPTORS, AND MEANS FOR MODULATION OF PROCESSES MEDIATED BY RETINOID X RECEPTORS | LIGAND PHARMACEUTICALS, INC. (US) | 1995-10-25 | — | — | EP | disclosed |
| EP-0637297-A4 | COMPOUNDS HAVING SELECTIVITY FOR RETINOID X RECEPTORS. | LIGAND PHARM INC (US) | 1995-09-20 | — | — | EP | disclosed |
| WO-1995004036-A1 | COMPOUNDS HAVING SELECTIVE ACTIVITY FOR RETINOID X RECEPTORS, AND MEANS FOR MODULATION OF PROCESSES MEDIATED BY RETINOID X RECEPTORS | LIGAND PHARMACEUTICALS INC. (US) | 1995-02-09 | — | — | WO | disclosed |
| EP-0637297-A1 | COMPOUNDS HAVING SELECTIVITY FOR RETINOID X RECEPTORS | LIGAND PHARMACEUTICALS, INC. (US) | 1995-02-08 | — | — | EP | disclosed |
| WO-1994015901-A1 | COMPOUNDS HAVING SELECTIVITY FOR RETINOID X RECEPTORS | LIGAND PHARMACEUTICALS INC. (US) | 1994-07-21 | — | — | WO | disclosed |
| WO-1993021146-A1 | COMPOUNDS HAVING SELECTIVITY FOR RETINOID X RECEPTORS | LIGAND PHARMACEUTICALS INCORPORATED (US) | 1993-10-28 | — | — | WO | disclosed |